Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin A--injection for cervical dystonia.

S Bhaumik1, M Behari

  • 1Dept. of Neurology, All India Institute of Medical Sciences, New Delhi, India.

The Journal of the Association of Physicians of India
|September 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opportunities for health system strengthening to reduce preventable trauma deaths in the Western Cape Province, South Africa: Findings from an expert panel review.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

Search for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing Run.

Physical review letters·2022
Same author

Constraints on Cosmic Strings Using Data from the Third Advanced LIGO-Virgo Observing Run.

Physical review letters·2021
Same author

Diabetes in adults with intellectual disability: prevalence and associated demographic, lifestyle, independence and health factors.

Journal of intellectual disability research : JIDR·2020
Same journal

Indian Expert Consensus on Allergic Rhinitis in Women: A Modified Delphi Survey.

The Journal of the Association of Physicians of India·2026
Same journal

Systematic Review of Topical Capsaicin 0.075% for the Treatment of Neuropathic Pain: Efficacy, Safety, and Tolerability.

The Journal of the Association of Physicians of India·2026
Same journal

Sodium-Glucose Cotransporter 2 Inhibitors in Kidney Diseases Other Than That Due to Diabetes: Benefits in Composite Renal Outcomes Driven by Immunoglobulin A Nephropathy.

The Journal of the Association of Physicians of India·2026
Same journal

<i>Fasciolopsis buski</i> Diagnosed by Upper Gastrointestinal Endoscopy.

The Journal of the Association of Physicians of India·2026
Same journal

"Academic Overdose" among Healthcare Professionals.

The Journal of the Association of Physicians of India·2026
Same journal

Respiratory Examination for Postgraduate Residents: Unrevealing Expert's Questions and Answers.

The Journal of the Association of Physicians of India·2026
See all related articles

Botulinum toxin-A (BTX-A) effectively treats cervical dystonia, a common neck disorder. This study found BTX-A safe and effective in 17 patients, with 86% showing significant improvement and minimal side effects.

Area of Science:

  • Neurology
  • Movement Disorders
  • Pharmacology

Background:

  • Spasmodic torticollis, also known as cervical dystonia, is the most prevalent form of focal dystonia.
  • Botulinum toxin-A (BTX-A) has been utilized for cervical dystonia treatment since 1985.
  • Previous medical therapies had been attempted by the patient cohort.

Purpose of the Study:

  • To evaluate the efficacy and safety of Botulinum toxin-A (BTX-A) in treating cervical dystonia.
  • To document the treatment experience in a cohort of patients with cervical dystonia.

Main Methods:

  • A retrospective analysis of 29 treatment sessions involving 17 patients with cervical dystonia.
  • Administration of Botulinum toxin-A (Botox and Dysport) targeting neck muscles like splenius capitis and sternocleidomastoid.

Related Experiment Videos

  • Assessment of dystonia improvement and pain reduction post-treatment, along with monitoring for adverse events.

    • Main Results:

    • Significant improvement in dystonia was observed in 86% (25 out of 29) of treatment sessions.
    • Four out of five patients reported improvement in pain.
    • Adverse events were infrequent, with only 10.4% of sessions resulting in mild complications such as dysphagia or flu-like symptoms.

    Conclusions:

    • Botulinum toxin-A (BTX-A) is a safe and effective therapeutic option for managing cervical dystonia.
    • BTX-A offers significant benefits in reducing dystonic symptoms and associated pain.
    • The treatment is well-tolerated, with a low incidence of mild adverse effects.